GlaxoSmithKline News
Most Popular GlaxoSmithKline Story
Ligand inks new development pact with Glaxo
San Diego-based Ligand Pharmaceuticals will pocket a $5 million upfront fee and up to $158 million in development and commercial milestones under a new pact it signed with GlaxoSmithKline covering... Read more...
Latest Headlines
- December 23, 2008
- December 18, 2008
- December 17, 2008
- December 12, 2008
- November 21, 2008
- November 10, 2008
- October 30, 2008
- October 23, 2008
- October 23, 2008
- October 15, 2008
- October 14, 2008
- October 1, 2008
- September 26, 2008
- September 15, 2008
- September 12, 2008
- September 10, 2008
- September 10, 2008
- August 28, 2008
- August 6, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
